This article is more than 5 years old. Information may no longer be current.
Top 10 endocrine news stories posted in 2018
Click Here to Manage Email Alerts
Endocrine Today has compiled a list of the top 10 news reports posted in 2018. This year, Healio.com/Endocrinology readers were interested in endocrine-disrupting chemicals in some essential oils and in store receipts, a thyroid tablet recall, new guidelines for PCOS care, diabetes technology, and more.
Two common essential oils contain endocrine-disrupting chemicals
Certain chemical components of lavender and tea tree oils have been identified as endocrine-disrupting chemicals, and a new study lends further evidence to suggest that topical use in prepubescent boys may lead to the development of male prepubertal gynecomastia.
Thyroid tablets recalled
Drug wholesaler Westminster Pharmaceuticals has issued a voluntarily recall of all unexpired levothyroxine and liothyronine 15-mg, 30-mg, 60-mg, 90-mg and 120-mg tablets, which are packaged in 100-count bottles, according to a company announcement.
Report: BPS replaces BPA in many store receipts
An analysis of more than 150 store receipts revealed that most no longer contain the endocrine-disrupting chemical bisphenol A; however, many now contain bisphenol S, which raises similar health concerns, according to a new report from the Ecology Center.
New international PCOS guideline aims to streamline care
An international consortium of polycystic ovary syndrome professional societies and organizations issued new evidence-based recommendations and practice points to promote consistent, evidence-based care and improve health outcomes for women with PCOS, according to a new guideline published in Fertility & Sterility.
Semaglutide produces weight loss in adults with obesity, without diabetes
Nearly two-thirds of adults with obesity and without diabetes who received daily injections of the GLP-1 receptor agonist semaglutide decreased their body weight by at least 10% compared with about one-third of those taking liraglutide, according to results of a phase 2 study.
FDA approves 14-day FreeStyle Libre CGM sensor for diabetes
The FDA approved the FreeStyle Libre flash glucose monitoring system, which allows patients with diabetes to wear the sensor up to 14 days with high accuracy.
Diabetes vaccine may follow from celiac disease research
The venture philanthropy organization JDRF T1D Fund is investing in ImmusanT, a clinical-stage company looking to develop a vaccine to prevent type 1 diabetes following on its peptide immunotherapy program for celiac disease, the two entities announced in a press release.
Despite benefits, intermittent fasting increases risk for hypoglycemia in type 2 diabetes
Intermittent fasting increased hypoglycemia among patients with type 2 diabetes who were treated with hypoglycemic medications, according to the results of a study conducted in New Zealand. However, fasting was also associated with improvements in weight, HbA1c and quality of life.
Food order affects glucose, insulin excursions in prediabetes
The order in which food is consumed during a meal subsequently affects blood glucose and insulin excursions in adults with prediabetes.
Mental health status may influence weight loss with intensive lifestyle intervention
Hispanic women with prediabetes and overweight or obesity who were assigned to an intensive lifestyle intervention for 1 year experienced a greater reduction in body weight if their mental health remained stable or improved vs. similar women whose mental health worsened during the same time, study data show.